Complement 3 Glomerulopathy clinical trials

Explore recruiting complement 3 glomerulopathy clinical trials.

Recruiting complement 3 glomerulopathy studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Complement 3 Glomerulopathy trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A multicenter, randomized, double-blind, parallel group, placebo-controlled study to evaluate the efficacy and safety of iptacopan (LNP023) in complement 3glomerulopathy

Germany, France, Spain, Slovakia, Netherlands, Greece +1 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

An Open-Label, Randomized, Controlled, Phase 2 Study to Evaluate the Safety and Efficacy of Pegcetacoplan in the Treatment of Post-Transplant Recurrence of C3G or IC‑MPGN

Netherlands, Austria, Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 3, Randomized, Placebo-Controlled, Double-Blinded, Multicenter Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Patients with C3 Glomerulopathy or Immune-Complex Membranoproliferative Glomerulonephritis

Austria, Netherlands, Italy, Germany

Therapeutic confirmatory (Phase III) EU CTIS Study details

Complement 3 Glomerulopathy trials by city

Complement 3 Glomerulopathy in Toronto Complement 3 Glomerulopathy in Vancouver Complement 3 Glomerulopathy in Montreal Complement 3 Glomerulopathy in Calgary Complement 3 Glomerulopathy in Edmonton Complement 3 Glomerulopathy in Ottawa Complement 3 Glomerulopathy in Winnipeg Complement 3 Glomerulopathy in Quebec City Complement 3 Glomerulopathy in Hamilton Complement 3 Glomerulopathy in Kitchener Complement 3 Glomerulopathy in London Complement 3 Glomerulopathy in Halifax Complement 3 Glomerulopathy in New York Complement 3 Glomerulopathy in Los Angeles Complement 3 Glomerulopathy in Chicago Complement 3 Glomerulopathy in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease